Nanogrowbiotech
1 known investors
NanoGrow Biotech develops biological therapies based on a single-domain antibody (nanobody) platform, combined with various formulations such as topical, inhaled, injectable, and oral delivery. Its targeted therapies address conditions including psoriasis, asthma, inflammatory bowel disease, and melanoma.
Investors · 1
Frequently asked questions
- What does Nanogrowbiotech do?
- NanoGrow Biotech develops biological therapies based on a single-domain antibody (nanobody) platform, combined with various formulations such as topical, inhaled, injectable, and oral delivery. Its targeted therapies address conditions including psoriasis, asthma, inflammatory bowel disease, and melanoma.
- Who are Nanogrowbiotech's investors?
- Nanogrowbiotech's investors include GRIDX.